Clinical Trial Update: Tobramycin Inhalation Powder (TIP) in Cystic Fibrosis Patients Infected With Burkholderia Cepacia Complex [Phase 1]

View source ↗

Summary

Phase 1 trial update for tobramycin inhalation powder in cystic fibrosis patients infected with Burkholderia cepacia complex; study completed with results poste…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Burkholderia Cepacia Infection
• Cystic Fibrosis

Drugs mentioned

• Tobramycin Inhalation Powder (tobramycin inhalation powder)

Snippet

Sponsor: Unity Health Toronto | Conditions: Cystic Fibrosis, Burkholderia Cepacia Infection | Phase 1 | Status: COMPLETED | Results posted: 2020-11-04